CXC-AG
CXC-AG is a division of CXC, solely focused on developing and commercializing research from top university laboratories. CXC-AG has strong links to McGill University, especially the Smith Lab which is renowned for developing lipochito-oligosaccharides (LCOs), which are arguably the biggest hit in biologicals, in use on hundreds of millions of acres worldwide.
BioFuelNet Canada Inks Research Deal with CXC-AG for 450 Bacterial Strains to Fight GHGs
The new strains have the potential to increase yields in the absence of abiotic stress.
Latest News
ABG Update Feature
AgriBusiness Global Report: Sarah Reiter of BioConsortia Talks Plant Health Trends in LATAM
BioConsortia’s Sarah Reiter explores Latin America’s plant health momentum,...
ABG Update Feature
Sustainable Podcast: How Certis Helps Growers Succeed With Biologicals
Certis Biologicals' Gregory Rogers explains how the company helps...
ABG Update Feature
Closing the Biological Gap: From Adoption Barriers to Innovation Breakthroughs
Biologicals promise sustainability, but adoption lags — here’s how...
Biostimulants
Staphyt and GenoScreen Join Forces to Offer Integrated Solutions in Genomics, Regulatory Studies and Field Trials
The alliance combines GenoScreen’s cutting-edge genomic technologies with Staphyt’s...